1. Explanation:
1. The time-series data of ILI occurrences in the past 5 weeks (Week20, 2023 to Week24, 2023) in Region 0 show a consistently decreasing trend: 1847 → 1762 → 1753 → 1592 → 1546. This suggests a gradual decline in ILI activity. The week-to-week percentage decreases are approximately -4.6% (Week20 to Week21), -0.5% (Week21 to Week22), -9.2% (Week22 to Week23), and -3.0% (Week23 to Week24), with some larger reductions closer to Week23, reflecting sharper declines in later weeks. The consistent downward trajectory indicates a seasonal shift likely tied to the flu off-season.
2. The target forecasting period, Week29, 2023, falls within the "Off-season," based on seasonal definitions. In the United States, off-season activity typically runs from Week7 to Week31 annually, characterized by minimal ILI activity and declining residual flu presence. While other respiratory illnesses may co-circulate, influenza transmission itself remains low during this period. Week29 is near the end of the off-season, suggesting ILI occurrences are likely to trend closer to baseline.
3. By analyzing the correlation between past trends and future occurrences, the average weekly ILI decline over the past 5 weeks is approximately -4.33% per week [(1546 - 1847) ÷ 5 weeks ÷ 1847 × 100]. Extrapolating this consistent decline to Week29 (5 weeks beyond Week24), the ILI occurrences can be projected using a sequential decay model:
4. - Week25: 1546 × (1 - 0.0433) ≈ 1479
5. - Week26: 1479 × (1 - 0.0433) ≈ 1415
6. - Week27: 1415 × (1 - 0.0433) ≈ 1354
7. - Week28: 1354 × (1 - 0.0433) ≈ 1295
8. - Week29: 1295 × (1 - 0.0433) ≈ 1240
9. However, further adjustments are necessary based on CDC-reported factors (below) to project a final value of 1092.
4. Three major factors from the CDC reports point toward low ILI occurrences for Week29, 2023:
5. Minimal influenza activity: From Week20-Week24, tested specimens consistently showed very low positivity rates (<1.2%), with influenza circulation steadily declining. For example, only 1.0%-1.1% positivity was reported in Week23 and Week24. Declining lab-confirmed influenza hospitalizations align with this trend, with levels decreasing from 953 in Week22 to 779 in Week24. This indicates a sharp reduction in influenza activity, contributing to the overall drop in ILI occurrences. Quantitatively, lower influenza positivity and hospitalization rates reduce the relative contribution of flu-related ILI cases to total instances, justifying a sharper decline in projections for Week29.
6. Off-season factor: CDC reports explicitly expect minimal flu activity throughout the summer. Respiratory viruses like RSV and SARS-CoV-2 may co-circulate, but their relative contribution to ILI remains lower compared to peak flu season. Modeling this seasonal adjustment further lowers projected ILI occurrences in Week29 by approximately 10%-15% compared to extrapolated off-season values based purely on historical data.
7. Pediatric and outpatient trends: Reports indicate outpatient visits for ILI have been steadily decreasing (2.0% in Week20 to 1.5% in Week24), with "minimal" reported ILI activity in most jurisdictions nationwide. Additionally, ILI trends among pediatric groups (a key driver of higher occurrences) show gradual reductions, consistent with the off-season decline in influenza-related outpatient visits. This context supports further quantitative downward adjustments to ILI forecasts for Week29.
5. In summary, the forecast of 1092 ILI occurrences for Week29, 2023, is derived from the consistent downward trend observed in historical data (notably -4.33% per week), the off-season designation for Week29, and CDC-confirmed minimal influenza activity during summer. The initial extrapolated value of 1240 was adjusted downward to account for off-season effects and reduced outpatient and pediatric illness rates, yielding a final prediction of 1092. These factors collectively indicate a continued decline in ILI activity, aligning with expectations for minimal flu prevalence during the off-season.